Molecularly targeted therapies for renal cell cancer: TRAIL research advances.
Buttyan
Ralph
R
Mian
Badar M
BM
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D040262:Receptors, Vascular Endothelial Growth Factor / Q000187:drug effects; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D040262:Receptors, Vascular Endothelial Growth Factor